Andrew Krivoshik

Andrew Krivoshik's work experience includes:

- Chief Medical Officer at Frontier Medicines starting in May 2023.

- President and Head of Development at Astellas Pharma US from September 2021 to April 2023.

- Senior Vice President and Head of Development Therapeutic Areas at Astellas Pharma US from April 2021 to March 2022.

- Senior Vice President and Oncology Therapeutic Area Head at Astellas Pharma US from April 2019 to August 2021.

- Vice President Medical Sciences - Oncology at Astellas Pharma US from April 2017 to March 2019.

- Executive Medical Director at Astellas Pharma US from December 2013 to March 2017.

- Senior Medical Director at Astellas Pharma US from March 2011 to November 2013.

- Senior Medical Director, Therapeutic Area Manager (Oncology)/Product Safety Team Lead at Abbott from December 2010 to March 2011.

- Senior Medical Director at Abbott from April 2010 to December 2010.

- Medical Director at Abbott from January 2007 to April 2010.

- Associate Medical Director at Abbott from January 2006 to January 2007.

- Assistant Medical Director at Abbott from July 2004 to January 2006.

- Pediatric Hematology/Oncology Fellow at Duke University Medical Center from July 2002 to June 2004.

- Pediatric and Adolescent Medicine Resident Physician at Mayo Graduate School of Medicine from June 1999 to June 2002.

- Supplemental Technician at IBM TJ Watson Research Center in 1989 and 1988.

Andrew Krivoshik began their education at The Pingry School, where they studied from 1981 to 1986. In 1981 and 1982, they also attended the Move Ahead Program at Stevens Institute of Technology. After completing high school, they enrolled at Princeton University, where they pursued a Bachelor of Science in Electrical Engineering with Honors from 1986 to 1990. Following their undergraduate studies, Andrew attended the University of Illinois Urbana-Champaign from 1990 to 1999. During this time, they were a combined MD-PhD candidate in Medicine and Biophysics through the Medical Scholars Program. In 1994, they earned a Doctor of Medicine (MD) degree from the University of Illinois College of Medicine at Urbana-Champaign. In 2001, Andrew completed their PhD in Biophysics and Computational Biology. Additionally, they undertook an internship and residency in Pediatric and Adolescent Medicine at the Mayo Clinic from 1999 to 2002. From 2002 to 2004, they specialized further in Pediatric Hematology-Oncology during a fellowship at Duke University. Additionally, Andrew briefly studied accident and emergency medicine at King's College London in 1999.